COMPASS THERAPEUTICS, INC. (CMPX) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$26.98M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$20.30M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$15.82M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$21.07M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2019-06-30 to 2021-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$26.98M | (m) | (m) | (m) | $176.00K* | -$14.74M* | (m) | (m) | (m) | (m) |
|---|
| 2026-03-31 | Reported | (m) | -$20.30M | (m) | (m) | (m) | $82.00K | -$17.27M | (m) | $13.39M | (m) | (m) |
|---|
| 2025-09-30 | Reported | (m) | -$15.82M | (m) | (m) | (m) | $7.00K* | -$10.85M* | (m) | $12.83M | (m) | (m) |
|---|
| 2025-06-30 | Reported | (m) | -$21.07M | (m) | (m) | (m) | $0.00* | -$11.83M* | (m) | $16.41M | (m) | (m) |
|---|
| 2025-03-31 | Reported | (m) | -$17.97M | (m) | (m) | (m) | $18.00K | -$13.21M | (m) | $13.05M | (m) | $0.00 |
|---|
| 2024-09-30 | Reported | (m) | -$12.24M | (m) | (m) | (m) | $44.00K* | -$11.05M* | (m) | $8.61M | (m) | (m) |
|---|
| 2024-06-30 | Reported | (m) | -$15.04M | (m) | (m) | (m) | $0.00* | -$10.75M* | (m) | $11.17M | (m) | $0.00 |
|---|
| 2024-03-31 | Reported | (m) | -$12.77M | (m) | (m) | (m) | $0.00 | -$13.89M | (m) | $9.52M | (m) | $0.00 |
|---|
| 2023-09-30 | Reported | (m) | -$11.93M | (m) | (m) | (m) | $10.00K* | -$5.92M* | (m) | (m) | (m) | $0.00 |
|---|
| 2023-06-30 | Reported | (m) | -$13.34M | (m) | (m) | (m) | $11.00K* | -$10.11M* | (m) | (m) | (m) | $0.00 |
|---|
| 2023-03-31 | Reported | (m) | -$9.71M | (m) | (m) | (m) | $0.00 | -$12.23M | (m) | (m) | (m) | $0.00 |
|---|
| 2022-09-30 | Reported | (m) | -$12.60M | (m) | (m) | (m) | $27.00K* | -$10.94M* | (m) | (m) | (m) | $0.00 |
|---|
| 2022-06-30 | Reported | (m) | -$8.99M | (m) | (m) | (m) | -$63.00K* | -$4.60M* | (m) | (m) | (m) | $0.00 |
|---|
| 2022-03-31 | Reported | (m) | -$7.18M | (m) | (m) | (m) | $194.00K | -$7.94M | (m) | (m) | (m) | $0.00 |
|---|
| 2021-09-30 | Reported | (m) | -$5.85M | (m) | (m) | (m) | $367.00K* | -$3.46M* | (m) | (m) | (m) | $0.00 |
|---|
| 2021-06-30 | Reported | (m) | -$55.69M | (m) | (m) | (m) | $296.00K* | -$5.94M* | (m) | (m) | (m) | $13.00K |
|---|
| 2021-03-31 | Reported | -$7.14M | (m) | (m) | (m) | (m) | $128.00K | -$5.61M | (m) | $4.70M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$6.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$8.56M | (m) | (m) | (m) | (m) | $7.00K* | -$7.17M* | (m) | $3.67M | (m) | $0.00 |
|---|
| 2020-06-30 | Reported | -$4.67M | (m) | (m) | (m) | (m) | $4.00K* | -$5.30M* | (m) | $2.98M | (m) | $16.00K |
|---|
| 2020-03-31 | Reported | -$5.33M | (m) | (m) | (m) | (m) | $12.00K | -$7.76M | (m) | $3.57M | (m) | $16.00K |
|---|
| 2019-12-31 | Reported | -$5.9M | (m) | (m) | (m) | (m) | (m) | -$7.24K* | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | -$7.88M | (m) | (m) | (m) | (m) | $27.00K* | -$6.70M* | (m) | $5.98M | (m) | $26.00K |
|---|
| 2019-06-30 | Reported | -$8.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.39M | (m) | $26.00K |
|---|
| 2018-12-31 | Reported | (m) | -$9.27K | (m) | (m) | (m) | (m) | -$10.27K* | (m) | (m) | (m) | (m) |
|---|
| 2018-09-30 | Reported | (m) | -$7.79K | (m) | (m) | (m) | (m) | -$4.79K* | (m) | (m) | (m) | (m) |
|---|
| 2018-06-30 | Reported | (m) | -$7.89K | (m) | (m) | (m) | (m) | -$7.89K | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$72.84M | (m) | (m) | (m) | $25.00K | -$49.14M | (m) | $55.97M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | (m) | -$56.63M | (m) | (m) | (m) | $44.00K | -$44.85M | (m) | $42.34M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | (m) | -$50.36M | (m) | (m) | (m) | $30.00K | -$40.62M | (m) | $38.12M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | (m) | -$41.66M | (m) | (m) | (m) | $212.00K | -$34.13M | (m) | (m) | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$81.28M | (m) | (m) | (m) | (m) | $1.57M | -$19.67M | (m) | (m) | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$25.41M | (m) | (m) | (m) | (m) | $106.00K | -$26.80M | (m) | $14.90M | (m) | $32.00K |
|---|
| 2020-09-30 | Rolling | (m) | -$19.87M* | (m) | (m) | (m) | (m) | -$20.24M* | (m) | (m) | (m) | (m) |
|---|
| 2020-06-30 | Rolling | (m) | -$19.29M* | (m) | (m) | (m) | (m) | -$19.77M* | (m) | (m) | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$32.10K | (m) | (m) | (m) | (m) | -$32.11K | (m) | (m) | (m) | (m) |
|---|
| 2020-03-31 | Rolling | (m) | -$22.90M* | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-12-31 | Reported | -$31.95M | (m) | (m) | (m) | (m) | $466.00K | -$31.74M | (m) | $22.45M | (m) | $91.00K |
|---|
| 2019-03-31 | Reported | (m) | -$32.76K | (m) | (m) | (m) | (m) | -$32.76K | (m) | (m) | (m) | (m) |
|---|